60¢sixtycents

GSK plcGSK

Is GSK cheap right now? Every multiple below is scored against its own 10-year range, not a sector average.

$48.68-0.06 (-0.12%)24:00 UTC
NYSEHealthcare

Company snapshot

Market Cap
$99B
Large-cap
+22%
2016 — today
10-Year Price
+18%
2016 — today
52-Week Range
$46.11$61.18
Current $48.68· 17%

GSK plc (formerly GlaxoSmithKline) researches, develops, and manufactures vaccines and specialty medicines globally. Organized into Commercial Operations and R&D, its portfolio includes immunizations for shingles, meningitis, RSV, and influenza, alongside treatments for HIV, oncology, respiratory conditions (asthma/COPD), and infections. Innovation is driven by strategic partnerships, including mRNA vaccine development with CureVac, oligonucleotide platforms with Wave Life Sciences, and research alliances for Parkinson’s and fibrotic diseases.

Similar companies

Healthcare companies of comparable size to GSK
CompanyP/EDiv yield
SNYSanofi78.65.6%
HCAHCA Healthcare, Inc.15.80.6%
ELVElevance Health Inc.18.01.6%
REGNRegeneron Pharmaceuticals, Inc.20.30.5%
CVSCVS Health Corporation23.92.9%
MCKMcKesson Corporation26.20.4%
SYKStryker Corporation33.21.1%
CICigna Corporation12.42.1%

Healthcare companies of comparable size — each one shown against its own 10-year range, not a sector average. Browse all stocks we cover.

Valuation in context

P/E ratio
16.9
Above average
Pricier than usual over the last 10 years
Sector median 25.4below sector
P/B ratio
4.0
Around average
Around the 10-year average
Sector median 2.2above sector
EV / EBITDA
10.9
Above average
Pricier than usual over the last 10 years
Sector median 15.7below sector
Dividend Yield
3.7%
Historically low
Historically low relative to the last 10 years
Sector median 1.8%above sector
FCF Yield
9.2%
Above average
Above the 10-year average
Sector median -12.6%above sector
Free · No credit card needed

Get alerted when GSK is cheap

Set a free alert — we'll push you when P/E, yield, or other metrics cross a historical threshold.